EDITORIAL
http://www.100md.com
《核酸研究医学期刊》
Nucleic Acids Research is pleased to announce that the journal will become fully Open Access beginning January 1, 2005. ALL papers published after that date will be made freely available at the NAR website and also at PubMed Central immediately upon publication.
In 2005 this will be funded by a combination of author charges, institutional membership and print subscriptions. For all papers published from January 1, 2005, there will be a nominal charge of $500 per paper for authors from institutions that hold NAR membership, whereas for authors from institutions without NAR membership the charge will be $1,500. In 2005 institutions can acquire NAR membership for the same price as the 2004 NAR online subscription. A slightly higher payment will enable the institute to also have a print subscription. There will be no charges for colour figures, and no page charges for papers that occupy 9 pages or less. Papers published after January 1, 2005 that occupy more than 9 pages will incur a charge of $50 for each page in excess of 9. Waivers or discounts will be considered sympathetically for corresponding authors from developing countries and those in genuine hardship. Further information is available from our website www.nar.oupjournals.org/openaccess. We are confident that in this way it will be possible for NAR, as a traditional, subscription-based journal, to move to an Open Access mode of publication on a sound financial basis. We hope that all of our authors and readers, as well as librarians and the funding agencies, will agree that Open Access publication is both desirable and worthy of continued support.
As Editors of NAR we believe strongly in the principles of Open Access publication, and the benefits they will bring to all users of the journal at all levels. The interests of authors and readers, teachers and students, are served best by immediate and unlimited access to the full contents of NAR. If other journals follow suit, then an increasing volume of scientific literature could soon be rendered into full digital form, and for the first time become completely searchable by anyone with a computer. In this way repositories, such as PubMed Central, may become the ‘GenBanks’ of scientific information.
For Open Access to become widely established, the participation of large governmental funding agencies will be critical. It is imperative that they recognize the value of unlimited access to the results of research and support this move by making provision for the costs of Open Access publication within grants and research allocations. Ultimately it is the taxpayers who have provided the funding for research. Under the conventional subscription system they have no free rights of access to the results of the research for which they have paid. However, with Open Access, these barriers will be removed.
We believe that a new era of scientific publication is beginning. Nucleic Acids Research is proud to join other, more recently founded, Open Access publications in aiming to show that Open Access is not just a scientist's pipe dream, but instead the key to the future of scientific achievement.
In 2005 this will be funded by a combination of author charges, institutional membership and print subscriptions. For all papers published from January 1, 2005, there will be a nominal charge of $500 per paper for authors from institutions that hold NAR membership, whereas for authors from institutions without NAR membership the charge will be $1,500. In 2005 institutions can acquire NAR membership for the same price as the 2004 NAR online subscription. A slightly higher payment will enable the institute to also have a print subscription. There will be no charges for colour figures, and no page charges for papers that occupy 9 pages or less. Papers published after January 1, 2005 that occupy more than 9 pages will incur a charge of $50 for each page in excess of 9. Waivers or discounts will be considered sympathetically for corresponding authors from developing countries and those in genuine hardship. Further information is available from our website www.nar.oupjournals.org/openaccess. We are confident that in this way it will be possible for NAR, as a traditional, subscription-based journal, to move to an Open Access mode of publication on a sound financial basis. We hope that all of our authors and readers, as well as librarians and the funding agencies, will agree that Open Access publication is both desirable and worthy of continued support.
As Editors of NAR we believe strongly in the principles of Open Access publication, and the benefits they will bring to all users of the journal at all levels. The interests of authors and readers, teachers and students, are served best by immediate and unlimited access to the full contents of NAR. If other journals follow suit, then an increasing volume of scientific literature could soon be rendered into full digital form, and for the first time become completely searchable by anyone with a computer. In this way repositories, such as PubMed Central, may become the ‘GenBanks’ of scientific information.
For Open Access to become widely established, the participation of large governmental funding agencies will be critical. It is imperative that they recognize the value of unlimited access to the results of research and support this move by making provision for the costs of Open Access publication within grants and research allocations. Ultimately it is the taxpayers who have provided the funding for research. Under the conventional subscription system they have no free rights of access to the results of the research for which they have paid. However, with Open Access, these barriers will be removed.
We believe that a new era of scientific publication is beginning. Nucleic Acids Research is proud to join other, more recently founded, Open Access publications in aiming to show that Open Access is not just a scientist's pipe dream, but instead the key to the future of scientific achievement.